Table 3.
Variable | Study group | M | SD | 95% CI | Range | p |
---|---|---|---|---|---|---|
Ganglion cell complex—total | Diabetic | 97.51 | 6.77 | 95.77–99.24 | 80.97–118.39 | 0.448 |
Nondiabetic | 98.08 | 6.03 | 96.25–99.92 | 87.23–111.94 | ||
GCC—superior quadrant | Diabetic | 96.05 | 10.45 | 93.38–98.73 | 30.88–117.00 | 0.371 |
Nondiabetic | 97.42 | 6.56 | 95.42–99.41 | 86.46–111.43 | ||
GCC—inferior quadrant | Diabetic | 98.05 | 8.49 | 95.88–100.23 | 81.69–138.14 | 0.401 |
Nondiabetic | 98.74 | 5.74 | 96.99-100.48 | 88.00–112.47 | ||
Focal loss volume (%) | Diabetic | 0.512 | 0.756 | 0.313–0.711 | 0.000–4.420 | 0.037 |
Nondiabetic | 0.275 | 0.434 | 0.142–0.407 | 0.000–2.202 | ||
Global loss volume (%) | Diabetic | 2.349 | 2.926 | 1.580–3.118 | 0.000–14.402 | 0.282 |
Nondiabetic | 1.842 | 1.909 | 1.262–2.422 | 0.003–8.265 |
M: mean; SD: standard deviation; CI: confidence interval.